# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-008596
Filing Date
2020-04-10
Accepted
2020-04-10 16:31:00
Documents
5
Effectiveness Date
2020-04-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | nc10009819x3_defa14a.htm | DEFA14A | 20403
2 |  | nc10009819x3_nc01.jpg | GRAPHIC | 775374
3 |  | nc10009819x3_nc02.jpg | GRAPHIC | 1045441
4 |  | nc10009819x3_nc03.jpg | GRAPHIC | 522225
5 |  | nc10009819x3_nc04.jpg | GRAPHIC | 115358
| Complete submission text file | 0001140361-20-008596.txt |  | 2852341

Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50865 | Film No.: 20786948
SIC: 2834 Pharmaceutical Preparations